[E]-5-(2-bromovinyl)-2'-deoxyuridine (BVdU) inhibits the replication of the baculovirus Trichoplusia ni multiple nucleocapsid nuclear polyhedrosis virus in Spodoptera frugiperda cells. Virus-specific DNA synthesis and late protein synthesis are suppressed by the drug. BVdU is phosphorylated by deoxythymidine (deoxycytidine) kinase present in both uninfected and virus-infected cells, and in its 5'-triphosphate form it inhibits DNA polymerase activity in virus-infected cells. The effect of the BVdU is not completely reversible. Phosphonoacetic acid, phosphonoformic acid and Acyclovir have no effect on baculovirus replication. Acyclovir fails to compete with deoxycytidine and thymidine as substrates for pyrimidine deoxynucleoside kinase in virus-infected and uninfected cells.
INTRODUCTION
Trichoplusia ni multiple nucleocapsid nuclear polyhedrosis virus (MNPV) is a large and complex virus that is pathogenic for some invertebrates, notably Lepidoptera. The replication of this virus can be inhibited by a number of DNA synthesis inhibitors including cytosine arabinoside, bromodeoxyuridine and hydroxyurea (Kelly & Lescott, 1976 . In this paper, we report the sensitivity of T. ni MNPV to other inhibitors of DNA virus replication, such as phosphonoformate, phosphonoacetate, 9-(2-hydroxyethoxymethyl)guanine (Acyclovir), and [E]-5-(2-bromovinyl)-2'-deoxyuridine (bromovinyldeoxyuridine; BVdU) (Mao et al., 1975; De Clercq et al., 1979; Helgstand et al., 1978 ; Schaeffer et al., 1978) . All four drugs act by inhibiting virus-specified DNA polymerase, although both Acyclovir and BVdU must first be phosphorylated to their triphosphates by the successive action of virus-induced deoxythymidine (deoxycytidine) kinase or cellular kinases before they can interact with DNA polymerase. Our investigation was aimed at the detection of drugs that would be useful for selecting MNPV mutants.
T. ni MNPV stimulates deoxythymidine kinase and DNA polymerase activities early in infection . When viral DNA synthesis is inhibited the virus fails to replicate and late proteins are not synthesized (Kelly & Lescott, 1981) , although deoxythymidine kinase and DNA polymerase activities are stimulated (Kelly, 1981a) . BVdU has proved to be a potent inhibitor of T. ni MNPV. The drug is a competitive inhibitor of deoxythymidine kinase and in its triphosphate form it inhibits DNA polymerase activity. BVdU inhibits viral DNA synthesis and considerably reduces the synthesis of late virus-specific proteins.
METHODS
Virus and cells. Spodopterafrugiperda cells (Vaughn et al., 1977) were grown in BML/TC 10 medium (Gardiner & Stockdale, 1975) . T. ni MNPV was grown and titrated in S. frugiperda cells as previously described (Kelly & Lescott, 1981) . X. WANG AND OTHERS Drugs. Acyclovir, phosphonoformic acid and phosphonoacetic acid were gi~fts. BVdU was synthesized according to a procedure similar to that described by Jones et al. (1979) . BVdU :5'-triphosphate was prepared essentially as described by Allaudeen et al. (1981) .
The effect of the drugs on virus replication was assessed by determining the yield of virus after 24 h incubation in the presence of the drug. Falcon 25 cm 2 flasks containing 106 cells were infected by adsorbing 1 ml of inoculum (2 × 107 p.f.u, virus) for 1 h at room temperature. The inoculum was removed and replaced with 5 ml of medium containing appropriate concentrations of drugs and the cells were incubated at 28 °C. After 24 h the cells were scraped into the medium, which was then sonicated, and the virus yield was determined by plaque assay.
Determination of deoxythymidine kinase, deoxycytidine kinase and DNA polymerase activities. These assays were performed in cell extracts as previously described . Deoxycytidine kinase activity was assayed in a 100rd reaction mixture containing 15 to 25 ~tg cell extract protein, 0-52 ~tM-[U-~C]deoxycytidine (0.25 ~tCi), 24.5 mM-ATP and 5 mM-MgC12. Infected cell extracts were buffered at pH 9-0; uninfected cell extracts were at pH 9.5, using 0.05 M-Tris-HC1. Incubation was performed at 28 °C for 90 min and the reaction was stopped by immersing the mixtures in a boiling water-bath for 2 min followed by cooling in ice. The denatured material was removed by centrifugation at 1000 g for 10 min. Deoxycytidine was separated from deoxycytidine nucleotides by descending chromatography on 2.5 x 46 cm DE81 cellulose paper (Whatman), using 1 mM-ammonium formate, for 5 h. The phosphorylated material remaining at the origin was cut out as a 6 x 2.5 cm strip, dried, and assayed by liquid scintillation spectrometry. Thymidine kinase was similarly assayed; the 100~tl reaction mixture contained 15 to 25 tzg protein of cell extract, 8-3 kLM-[2-taC]thymidine (0-05/.tCi), 24-5 mM-ATP, 10 mM-Mg 2÷ (5 mM in uninfected cell extracts), 0-05 i-Tris HCI pH 9.0. In DNA polymerase assays a pH of 9.0 and 10 mMMg 2+ were used for infected cells, and a pH of 7.5 and 2.5 mM-Mg 2÷ were used for uninfected cells.
Radiolabelling of cells. Radiochemicals were purchased from Amersham International. L-[35S]methionine (300 Ci/mmol) was added at 20 ktCi/ml in methionine-free medium (Kelly & Lescott, 1981) .
[32p]Orthophosphate was added at 100 ~tCi/ml in phosphate-free medium.
SDS polyacrylamide gel electrophoresis ofcellproteins. Radiolabelled cells were washed with phosphate-buffered saline, drained and scraped into 250 p.l of 2~ SDS, 2~o (v/v) 2-mercaptoethanol, 10~ (v/v) glycerol, 0-01 ~ (w/v) bromophenol blue in 1.0 ~-Tris-HC1 pH 6-8. Polypeptides were resolved on 16 cm-long 12~ polyacrylamide slab gels using the buffer system of Laemmli (1970) as previously described (Elliott et al., 1977) .
Agarose gel electrophoresis of cell DNA. D NA was extracted from 32 P-labelled cells by the method of Archard & Mackett (1979) . DNA was digested with the restriction enzymes BamHI or XhoI and resolved on submerged horizontal 0.6~ agarose gels as described by Kelly et al. (1980) .
RESULTS

Effects of inhibitors of DNA synthesis on T. ni MNPV replication
Incubation of cells infected at a multiplicity of infection (m.o.i.) of 120 in the presence of 0.3, 3.0, 30 or 100~tM-phosphonoacetic acid, -phosphonoformic acid or -Acyclovir showed no reduction in virus yield over a 24 h period. BVdU, as shown in Fig. 1 , was a potent inhibitor of T. ni MNPV replication, with a concentration of 1.5 ~tM inhibiting replication by approximately 50%.
BVdU was irreversible in its effect. Treatment of cells for 15 h (the duration of viral DNA synthesis; D. C. Kelly, unpublished observations), and then washing out the drug with five media rinses, followed by addition of fresh media failed to restore the virus yields at 24 h or 36 h to normal (Fig. 2) .
BVdU caused no cytopathic effect to uninfected cells at concentrations of 200 tXM and lower. BVdU did however have an effect on the rate of replication of the cells, extending the doubling time from 24 h to 30 h in the presence of 45 ktM-BVdU and to 48 h in the presence of 200 [.tMBVdU. This rate of inhibition of cell growth is unlikely to have a direct effect on virus replication since the virus normally inhibits cell growth, and can replicate to normal titres in cells which have been artificially inhibited with drugs such as rifampicin (Kelly & Lescott, 1976) .
Effect of BVdU on viral protein and DNA synthesis
Addition of BVdU (20 ~tM) considerably delayed the induction of late and very late virus polypeptide synthesis as shown in Fig. 3 . ICSP 75, which is probably the major virus envelope polypeptide, is a typical late protein, and ICSP 34, the polyhedron protein, typifies a very late protein (Kelly & Lescott, 1981) , and both are considerably delayed in their induction. The polyhedron protein (ICSP 34) normally detected 18 h post-infection is barely synthesized by 30 h after infection and the major glycosylated envelope polypeptide (ICSP 75; a late Y polypeptide) is detected in reduced amounts at 18 h and increased amounts at 30 h when its synthesis is normally considerably reduced. Little viral DNA synthesis was detected by restriction enzyme digestion of total cell DNA from cells radiolabelled with [32p]orthophosphate from 8 to 22 h after infection and observation of virus DNA fragments (Fig. 4) . The viral DNA synthesis is less than 5~ of the amount normally synthesized in ceils and this may correlate with the 8 to 10~ virus yield achieved at this drug concentration (Fig. I) .
Effect of BVdU and Acyclovir on deoxythymidine (deoxycytidine) kinase activity of virusinfected and uninfected cells
Acyclovir (20 to 90 ~tM) had no effect on deoxythymidine kinase or deoxycytidine kinase activity of virus-infected or uninfected cell extracts. These concentrations of Acyclovir represent up to a 180-fold excess of drug over substrate. BVdU was a potent competitive inhibitor of both deoxythymidine kinase and deoxycytidine kinase activity of infected and uninfected cells (Fig.  5) . The Ki for deoxycytidine kinase activity in infected cells was 0-2 txM and in uninfected cells _was 0.07 ~tM. The K i for deoxythymidine kinase activity in infected cells was 0.67 ~tM and in uninfected cells was 0.25 ~tM. 
Effect of BVdU and B VdU triphosphate on DNA polymerase activity of virus-infected and uninfected cells
BVdU triphosphate was a potent inhibitor of D N A polymerase activity of virus-infected cells and also inhibited, to a lesser extent, the D N A polymerase activity of uninfected cells (Fig. 6) . At 20 ~tM-BVdU, the induced enzyme was inhibited 95 ~ whereas the cell enzyme was inhibited by 50~. BVdU, unphosphorylated, also inhibited D N A polymerase activity in these crude cell extracts (Fig. 6 ).
DISCUSSION
Phosphonoformate, phosphonoacetate and Acyclovir appear to have no effect on the replication of T. ni MNPV. We have previously shown that PFA and PAA do not affect D N A polymerase activity in infected cells . In this study we have shown that Acyclovir has no effect on deoxythymidine (deoxycytidine) kinase activity of infected or uninfected cells and so Acyclovir is unlikely to be phosphorylated to its triphosphate. As a consequence D N A polymerase activity and baculovirus replication are not inhibited by Acyclovir. BVdU has been shown to be a potent inhibitor of MNPV replication, which is in accord with its established efficacy against some herpesviruses, such as herpes simplex virus and varicellazoster virus (De Clercq et al., 1980) . Addition of BVdU to T. ni MNPV-infected cells resulted in an almost complete inhibition of viral DNA synthesis. Late protein synthesis, mainly virus structural protein synthesis, was also suppressed. Similar observations have been made with this virus-cell system with bromodeoxyuridine, cytosine arabinoside, and hydroxyurea (Kelly & Lescott, 1976 Kelly, 1981 b) . This provides additional evidence that inhibition of virusspecific DNA replication leads to a reduction in the synthesis of late and very late virus proteins.
The mechanism of inhibition of DNA synthesis by BVdU in MNPV-infected cells is similar to that observed for herpes simplex virus-infected cells (Allaudeen et al., 1981) . The agent is presumably phosphorylated to BVdU triphosphate by pyrimidine nucleoside and nucleotide kinases present in infected and uninfected S. frugiperda cells. It is not yet clear whether the enzyme induced in virus-infected cells is a virus gene product. The 5'-triphosphate derivative of BVdU then inhibits the virus-induced DNA polymerase present so as to prevent virus replication. The direct effect of BVdU on DNA polymerase activity in crude cell extracts is probably attributable to its phosphorylation under the assay conditions.
The demonstration that BVdU inhibits baculovirus replication means that the drug can be used to select for mutants of the virus. We intend to look at the prophylactic effects of BVdU on the replication of baculoviruses in insect larvae since the drug may be useful in preventing baculovirus infections in such beneficial insects as silkworms and butterflies, species with aesthetic value. 
